Krystal Biotech (KRYS) FCF Margin (2023 - 2026)
Krystal Biotech recorded quarterly FCF Margin of 62.94% in Q1 2026, down 10.2% quarter-over-quarter from 70.09% in Q4 2025, and up 2940.0% year-over-year from 2.07% in Q1 2025.
Krystal Biotech's FCF Margin history runs 4 years deep, the most recent figure standing at 62.94% for Q1 2026.
- In Q1 2026, FCF Margin rose 2940.0% year-over-year to 62.94%; the TTM figure through Mar 2026 stood at 57.87% (up 1549.0% YoY), while the FY2025 annual figure was 50.83%, up 981.0% from the prior year.
- FCF Margin came in at 62.94% for Q1 2026 at Krystal Biotech, down from 70.09% in the prior quarter.
- In the past five years, FCF Margin ranged from a high of 70.09% in Q4 2025 to a low of 249.31% in Q3 2023.
- A 4-year average of 13.39% and a median of 47.94% in 2025 frame the typical range for FCF Margin.
- Across the five-year window, FCF Margin surged 31826 bps in 2024 and slumped 2075 bps in 2025, its largest moves.
- Krystal Biotech's FCF Margin stood at 11.23% in 2023, then surged by 609 bps to 57.12% in 2024, then advanced by 23 bps to 70.09% in 2025, then retreated by 10 bps to 62.94% in 2026.
- According to Business Quant data, FCF Margin over the past three periods registered 62.94%, 70.09%, and 48.2% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | -3.98% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 43.35% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 23.53% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 4.17% |
| 10 | Krystal Biotech | 9.05 Bn | 8.23 Bn | 110.03 Mn | 62.94% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 62.94% |
| Dec 31, 2025 | 70.09% |
| Sep 30, 2025 | 48.20% |
| Jun 30, 2025 | 47.94% |
| Mar 31, 2025 | 33.53% |
| Dec 31, 2024 | 57.12% |
| Sep 30, 2024 | 68.95% |
| Jun 30, 2024 | 2.70% |
| Mar 31, 2024 | 16.41% |
| Dec 31, 2023 | -11.23% |
| Sep 30, 2023 | -249.31% |